GC31083
DWK-1339 (MDR-1339)
Also known as 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)-1-benzofuran
DWK-1339 (MDR-1339) (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease
ChemicalCAS1018946-38-7MW326.39FormulaC20H22O4
- CAS number
- 1018946-38-7
- Molecular weight
- 326.39
- Formula
- C20H22O4
- Solubility
- DMSO ： ≥ 83·3 mg/mL (255·22 mM)
- InChIKey
- CUEPJIGXQLIOIK-UHFFFAOYSA-N
- Catalogue number
- GC31083
- Brand
- GLPBIO
Computed properties PubChem CID 24764491 · XLogP 4.4 · TPSA 40.8 Ų · H-bond donors 0
- XLogP
- 4.4
- TPSA
- 40.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Rotatable bonds
- 7
- Heavy atoms
- 24
SMILES COCCCC1=CC2=C(C=C1)OC(=C2)C3=CC(=C(C=C3)OC)OC
Computed descriptors from PubChem (CID 24764491), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il